Center Laboratories, Inc. (TPEX:4123)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
30.40
+0.85 (2.88%)
Sep 8, 2026, 1:30 PM CST

Center Laboratories Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,6571,5161,6181,394767.72500.11
Revenue Growth
3.63%-6.29%16.06%81.58%53.51%-30.25%
Gross Profit
716.93621.26748.95618.09406.27259.66
Operating Income
55.59-361.62234.0678.56284.12-254.15
Net Income
1,0199,323-1,104-995.42102.221,816
Earnings Per Share
1.2710.90-1.41-1.360.142.52
EPS Growth
-----94.29%-53.20%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Fenghua Sector/Department
750.94576.17646.91446.06--
Pharmaceutical Division
908.37941.1971.71950.53767.8500.31
Shengzhi Venture
20.2123.1720.8216.14--
Adjustment and Write-Off
-22.87-24.26-21.57-18.72-1.52-1.64
Total
1,6571,5161,6181,394767.72500.11

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3,606662.822,0503,4242,3484,849
Total Debt
4,1014,7046,5305,6213,4685,362
Net Cash (Debt)
-494.97-4,041-4,480-2,197-1,120-512.52
Net Cash Growth
------
Net Cash Per Share
-0.58-4.68-5.72-3.00-1.58-0.70

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
283.1627.16394.74-963.44-189.88-358.14
Capital Expenditures
-154.71-205.5-174.17-169.4-7.28-7.55
Free Cash Flow
128.45-178.34220.56-1,133-197.16-365.69
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
43.28%40.98%46.29%44.34%52.92%51.92%
Operating Margin
3.36%-23.85%14.47%5.63%37.01%-50.82%
Pretax Margin
98.55%763.01%-72.32%-79.91%-76.71%519.02%
Profit Margin
61.51%614.88%-68.22%-71.41%13.31%363.16%
FCF Margin
7.75%-11.76%13.63%-81.27%-25.68%-73.12%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.6641.6640.7141.3600.8251.799
Dividend Per Share Growth
141.17%132.88%-47.46%64.88%-54.16%83.29%
Dividend Yield
5.52%4.42%1.93%3.75%2.38%4.86%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
23.923.33--275.2216.82
Forward PE
-21.7321.7321.7321.7321.73
P/FCF Ratio
187.21-143.23---
PS Ratio
14.5220.4819.5321.9736.6461.10